MRTX1133
id:
mrtx1133-210-256622
title:
MRTX1133
text:
MRTX1133 is an investigational drug that targets the G12D mutation in KRAS dependent cancers. It is currently in a phase 1/2 clinical trial for the treatment of solid tumors. MRTX1133 is considered to be harmful from direct skin or eye exposure other than transient irritation. It may cause irritation of the respiratory system if inhaled.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/MRTX1133
date created:
2024-02-18T11:05:29Z
date modified:
2024-09-11T20:04:31Z
main entity:
{"identifier":"Q124735203","url":"https://www.wikidata.org/entity/Q124735203"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/af/MRTX1133.svg","width":166,"height":106}
fields total:
13
integrity:
16